Combining HPLC separation with radioimmunoassay solved the problem of measuring tiny amounts of opioid peptides in complex body fluids.
HPLC + RIA combinationSolved sensitivity and specificity problems for opioid peptide measurement
What the researchers found
The new method combined HPLC (high-performance liquid chromatography) with radioimmunoassay (RIA) to measure opioid peptides in human cerebrospinal fluid, plasma, and tissues.
The key advantage: HPLC first separates beta-endorphin from its precursor beta-lipotropin and from other opioid peptides. Then RIA measures each fraction individually. This eliminates cross-reactivity, where antibodies confuse one peptide for another.
The method uses volatile solvents that evaporate cleanly without interfering with the antibody tests. This was the first combined method that could accurately measure endorphin, enkephalin, and dynorphin families in the same sample.
Preliminary results from chronic pain patients' CSF were presented, demonstrating the method's practical utility.
Why it matters
Accurate measurement of opioid peptides in body fluids had been nearly impossible because antibody tests could not distinguish between similar peptides. This method solved that problem and enabled reliable research on opioid peptides in pain, addiction, and neurological disease.
How the study worked
HPLC separation using volatile solvents, followed by fraction collection and radioimmunoassay for specific opioid peptides. Tested on human cerebrospinal fluid, plasma, and tissue samples. Method validation included recovery, specificity, and reproducibility tests.
What this study cannot tell us
Methods paper with limited clinical data. Only a small group of chronic pain patients was tested. The method is labor-intensive compared to direct RIA. Sensitivity limits were not fully detailed.
How to read the evidence
Preliminary — technical methodology paper without clinical validation.
When this study was published
Published in 1987 — advanced the field by enabling more accurate peptide measurements.
The bigger picture
Reliable measurement of opioid peptides in body fluids is essential for pain research, addiction medicine, and understanding neurological diseases.
Questions still open
- Could this method be automated for clinical use?
- How do opioid peptide levels differ between pain conditions?
Common questions
Why is measuring opioid peptides difficult?
What is HPLC?
Read the original research
Combined high-performance liquid chromatographic-radioimmunoassay method for the analysis of endorphins, enkephalins and other neurotransmitter peptides.
Journal of chromatography, 423, 93-104
Citation
Venn, R F. (1987). Combined high-performance liquid chromatographic-radioimmunoassay method for the analysis of endorphins, enkephalins and other neurotransmitter peptides.. Journal of chromatography, 423, 93-104.